Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Trahan JeremyGeneral Counsel | Option exercise | M | — 1,221 sh | Jan 21, 2026 |
| 15 | Comerchero Marc D.Principal Accounting Officer | Grant or award | A | — 179 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Tax withholding | F | $24K 280 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Kovac MilanDirector | Grant or award | A | — 1,325 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Hazelbaker JillSee Remarks | Option exercise | M | — 1,465 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 1,191 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Option exercise | M | — 1,120 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Hazelbaker JillSee Remarks | Option exercise | M | — 1,494 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Trotta MatteoEVP, GM, Dermatology US | Grant or award | A | — 8,542 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Weitzel Gregory ThomasCFO | Option exercise | M | — 2,254 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Fredman Sheara JChief Accounting Officer | Grant or award | A | — 4,366 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 15 | Krishnamurthy NikkiSVP and Chief People Officer | Tax withholding | F | $42K 499 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 13 | Wagner ScottDirector | Option exercise | M | — 31.4K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 13 | Sanden BlayneSVP & PAO | Grant or award | A | $24K 750 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 13 | Bluestone JeffreyDirector | Option exercise · 10b5-1 plan | M | $337K 5,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 13 | Heitz Michael JohnChief Financial Officer | Tax withholding | F | $21K 636 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Radigan Elizabeth ChristineEVP, Chief Administrative Ofcr | Tax withholding | F | $53K 757 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Baur Frank TobiasEVP, Chief Operating Officer | Tax withholding | F | $50K 716 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | DeSantis Dean10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Olmstead NathanSVP and CFO | Tax withholding | F | $60K 2,988 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | DeSantis Dean10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Marquez OctavioDirector, President and CEO | Tax withholding | F | $219K 3,136 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Milmoe William H.10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 12 | Milmoe William H.10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Myers JonathanEVP, Chief Revenue Officer | Tax withholding | F | $73K 1,047 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $23K 396 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 12 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | — 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Clark Joseph GatesSVP and Pres, Optimized LED | Tax withholding | F | $51K 2,564 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 12 | Smith DironEVP, Chief Financial Officer | Tax withholding | F | $73K 848 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 12 | Kuykendall AnneSVP and Chief Legal Officer | Tax withholding | F | $67K 3,379 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 11 | Smith DironEVP, Chief Financial Officer | Grant or award | A | — 7,091 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Sweeny NicoleChief Commercial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Issa Mohamed KhairieEVP, Head of US Oncology | Grant or award | A | — 14.2K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Mayes Patrick AEVP & Chief Scientific Officer | Grant or award | A | — 4,218 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Piekos BrianChief Financial Officer | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Small MartinCFO & Senior Managing Director | Option exercise | M | — 27.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Audhya Paul K.CHIEF MEDICAL OFFICER | Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 11 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $28K 1,440 sh | Jan 21, 2026 traded Jan 21, 2026 |
| 11 | Tray ThomasPrincipal Accounting Officer | Grant or award | A | — 2,425 sh | Jan 21, 2026 traded Jan 16, 2026 |